Very early medical abortion (VEMA) could be a safe and reliable option for ending a pregnancy, even in cases of undiagnosed ectopic pregnancies.

The practice of ending a pregnancy is becoming more widespread. Clinics and hospitals currently postpone medication abortion until an ultrasound confirms the pregnancy is inside the uterus. However, a large international study conducted by researchers from Karolinska Institutet suggests that treatment can be just as effective and safe even before the sixth week of pregnancy. The study is published in The New England Journal of Medicine (1^✔ ✔Trusted Source
Randomized Trial of Very Early Medication Abortion

Go to source

).

Is a 6-week Abortion Safe?

35,550 abortions took place in Sweden in 2023, over 60 percent of them before the end of the seventh week of pregnancy. Often, the procedure is held off until intrauterine pregnancy is confirmed by vaginal ultrasound to rule out the possibility of an ectopic pregnancy, in which the embryo attaches outside the uterus, usually in the fallopian tubes. An ectopic pregnancy is not terminated by a medication abortion and can be life-threatening for the woman. Ultrasound reveals a pregnancy in week five to six.

“Women often find out very early if they’re pregnant, and a majority also know if they want a termination and if so, want it to take place as quickly as possible,” says the study’s first author Karin Brandell, gynaecologist at Karolinska University Hospital and doctoral student at the Department of Women’s and Children’s Health, Karolinska Institutet, Sweden. “Observational studies have produced contradictory results as regards effectiveness, so we wanted to study if very early abortion is just as effective and safe as waiting.”

Analyzing Very Early Medical Abortion (VEMA) Across Nine Nations

The VEMA (Very early medical abortion) study included over 1,500 women at 26 clinics in nine countries who requested an abortion before ultrasound was able to confirm intrauterine pregnancy. They were randomly assigned to either a delayed abortion once pregnancy could be confirmed in the uterus (in week 5 to 6) or to early abortion (in week 4 to 6). Both groups received two drugs – mifepristone and misoprostol.

At the start of the study, all participants were up to six weeks pregnant and presented no symptoms of ectopic pregnancy (e.g. abdominal pain or bleeding) or risk factors for such a pregnancy (e.g. pregnancy despite a coil or previous ectopic pregnancies). The outcome measure was terminated pregnancy (complete abortion).

“Very early medical abortion was just as effective and safe to perform, even in case of an undiagnosed ectopic pregnancy,” says Kristina Gemzell-Danielsson, professor of obstetrics and gynaecology at the same department at Karolinska Institutet, senior physician at Karolinska University Hospital and project leader of the VEMA study.

Is Abortion a Political Issue?

In both groups, over 95 percent of the women had a complete abortion, but the few procedures that failed differed between the groups. On delayed treatment, the treatment was incomplete in 4.5 percent of cases and required additional vacuum aspiration (surgery). In 0.1 percent of cases, the pregnancy continued. In the early group, the pregnancy continued in 3 percent of cases and 1.8 percent required surgery for incomplete abortion. A total of 1 percent of all participants had an ectopic pregnancy.

The women in the early group reported less pain and bleeding. In both groups, the women also expressed a desire to have the abortion performed as quickly as possible.

“Abortion is a political as well as a medical issue,” says Dr. Brandell. “In Sweden, a woman can repeat the procedure a week after a failed early abortion. But a woman in Texas, where abortion is banned after the sixth week, can’t. It was therefore important to show that early abortion is equivalent to current standard procedure at a later stage of pregnancy.”

Better Abortions and Contraceptives

The researchers now want to test if a new combination of drugs for early abortion is also effective for ectopic pregnancies. They are also developing new contraceptives based on one of the components of current medical abortions, mifepristone.

“It can be taken in a lower dose than for abortion to prevent unwanted pregnancies in the form of one tablet a week, or when needed,” says Professor Gemzell-Danielsson.

References:

1. Randomized Trial of Very Early Medication Abortion – (https://www.nejm.org/doi/10.1056/NEJMoa2401646)

Source-Eurekalert